Search clinical trials for: AZD8835
Total 108 results
-
AstraZenecaCompletedHealthy Volunteers | Alzheimer's Disease | Tolerability | Safety | Blood ConcentrationUnited Kingdom
-
AstraZenecaTerminated
-
AstraZenecaQuotient SciencesCompletedHealthy VolunteersUnited Kingdom
-
AstraZenecaActive, not recruitingER+ HER2- Advanced Breast CancerJapan
-
AstraZenecaParexelCompleted
-
AstraZenecaParexelTerminated
-
AstraZenecaParexelCompleted
-
AstraZenecaCompletedAdvanced Solid MalignanciesRussian Federation, Germany
-
AstraZenecaCompletedHealthyUnited Kingdom
-
AstraZenecaCompleted
-
AstraZenecaParexelCompleted
-
AstraZenecaCompletedAdvanced Solid MalignanciesJapan
-
AstraZenecaCompletedHealthyUnited Kingdom
-
AstraZenecaCompletedAdvanced Solid Malignancies | Breast Cancer - ER+, HER2 - | Breast Cancer - ER+, HER2-, PIK3CA Gene MutationUnited States, United Kingdom
-
AstraZenecaCompletedHeart Failure With Preserved Ejection FractionUnited States, France, Netherlands, Belgium, Taiwan, Slovakia, Japan, Czechia, Hungary, Australia, Bulgaria, Poland, Russian Federation, Brazil, Denmark, Turkey, Sweden, Canada
-
AstraZenecaParexelCompletedHeart Failure With Preserved Ejection Fraction (HFpEF)United States
-
AstraZenecaTerminated
-
AstraZenecaCompletedAsthmaUnited States, Germany, United Kingdom
-
AstraZenecaTerminatedHeart FailureDenmark, Finland, Netherlands, United States, Sweden
-
Mayo ClinicNational Center for Advancing Translational Sciences (NCATS)Completed
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Poland
-
AstraZenecaCompletedNon-Cirrhotic Non-alcoholic Steatohepatitis With FibrosisDenmark, Italy, Spain, United States, Argentina, Sweden, Mexico, Norway, Portugal
-
AstraZenecaCompletedHepatic ImpairmentUnited States, Bulgaria, Slovakia
-
AstraZenecaParexelCompletedCardiovascular DiseaseUnited States
-
AstraZenecaCompletedHealthy VolunteersSweden
-
AstraZenecaCompleted
-
AstraZenecaRecruitingChronic Obstructive Pulmonary Disease (COPD)United States, Canada, Denmark, Germany, South Africa, Spain, United Kingdom, Italy, Argentina, Bulgaria, Mexico, Turkey, Poland, Netherlands
-
AstraZenecaCompleted
-
AstraZenecaQuotient SciencesCompletedCardiovascular DiseaseUnited Kingdom
-
AstraZenecaQuotient SciencesCompleted
-
AstraZenecaCompleted
-
AstraZenecaParexelCompleted
-
AstraZenecaIqvia Pty LtdActive, not recruitingCOVID-19United States, Belgium, France, Spain, United Kingdom
-
AstraZenecaActive, not recruitingER+ HER2- Advanced Breast CancerUnited States, Spain, United Kingdom
-
AstraZenecaRecruitingBreast Cancer | Ovarian Cancer | Endometrial Cancer | Biliary Tract CarcinomaUnited States, Spain, Australia, United Kingdom, Korea, Republic of, Belgium, Canada, China, Japan, Taiwan, Thailand, Hungary, Poland, Netherlands
-
AstraZenecaCompletedHER2-negative Breast CancerMexico, United Kingdom, Georgia
-
AstraZenecaCompleted
-
AstraZenecaParexelCompletedSafety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of AZD8871 in Healthy SubjectsChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
AstraZenecaParexel; Covance; The Doctors Laboratory; Industrias Farmacéuticas Almirall S.A.CompletedChronic Obstructive Pulmonary Disease - COPDUnited Kingdom
-
AstraZenecaTerminatedThrombin InhibitionUnited States
-
AstraZenecaCompletedGERD Without Erosive EsophagitisSweden, United States, France, Italy, United Kingdom, Germany, Denmark, Finland, Norway, Canada
-
AstraZenecaCompletedSolid TumorsUnited States, France, United Kingdom
-
AstraZenecaCompletedAsthma (Part 1) | COPD (Part 2)United Kingdom
-
AstraZenecaRecruitingHepatic ImpairmentUnited States
-
AstraZenecaCompletedButyrylcholinesterase DeficiencyDenmark
-
AstraZenecaCompletedGERD With Erosive EsophagitisSweden, United States, France, Italy, United Kingdom, Germany, Denmark, Finland, Norway, Canada